Your browser doesn't support javascript.
COVID-19 vaccination for pregnant women: strategies for enhanced coverage
Indian Journal of Community Health ; 33(3):539-540, 2021.
Article in English | CAB Abstracts | ID: covidwho-1623066
ABSTRACT
Following the recommendations from the National Technical Advisory Group (NTAG) on Immunization, the Government of India approved three vaccines - an inactivated vaccine, Covaxin and two non-replicating vector-based vaccines, Covishield and Sputnik V for restricted use in an emergency for pregnant women.(1)The late approval of vaccination of pregnant women was due to a lack of evidence, because pregnant women were excluded from previous COVID vaccination trials. The restricted use of this vaccine recommended by NTAG also complies with the regulations of the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics. (2-4).
Keywords

Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Topics: Vaccines Language: English Journal: Indian Journal of Community Health Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Topics: Vaccines Language: English Journal: Indian Journal of Community Health Year: 2021 Document Type: Article